<DOC>
	<DOC>NCT00259662</DOC>
	<brief_summary>This study is designed to determine if the use of atorvastatin (Lipitor), a member of the HMG coA reductase inhibitor class of drugs referred to as statins, will reduce inflammatory responses and deep vein thrombosis formation when given in high doses in the perioperative period.</brief_summary>
	<brief_title>High-dose Periop Statins for Prevention of DVT</brief_title>
	<detailed_description />
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>gynecologic tumor scheduled for resection prior reaction to statins renal insufficiency liver disease h/o alcoholism prior h/o DVT or hypercoagulability concurrent medications that significantly affect cytochrome P450 3A4 breast feeding or pregnancy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>cancer--ovarian</keyword>
	<keyword>cancer--endometria</keyword>
	<keyword>deep vein thrombosis</keyword>
	<keyword>statin therapy in perioperative period</keyword>
</DOC>